» Articles » PMID: 15518236

Role of the Cripto (EGF-CFC) Family in Embryogenesis and Cancer

Overview
Journal Growth Factors
Publisher Informa Healthcare
Specialty Biology
Date 2004 Nov 3
PMID 15518236
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Elevated serum Cripto-1 and VEGF levels in patients with non-small cell lung cancer.

Xu C, Zou J, Li L, Yuan Q, Wang W FASEB Bioadv. 2022; 4(8):539-546.

PMID: 35949510 PMC: 9353448. DOI: 10.1096/fba.2022-00002.


High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection.

Zhang Y, Xu H, Chi X, Fan Y, Shi Y, Niu J Medicine (Baltimore). 2018; 97(35):e11781.

PMID: 30170372 PMC: 6392992. DOI: 10.1097/MD.0000000000011781.


High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.

Park K, Moon Y, Raffeld M, Lee D, Wang Y, Giaccone G Lung Cancer. 2018; 116:38-45.

PMID: 29413049 PMC: 8057110. DOI: 10.1016/j.lungcan.2017.12.010.


Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.

Ruggiero D, Nappo S, Nutile T, Sorice R, Talotta F, Giorgio E PLoS Genet. 2015; 11(1):e1004976.

PMID: 25629528 PMC: 4309561. DOI: 10.1371/journal.pgen.1004976.


Cripto-1 expression and its prognostic value in human bladder cancer patients.

Wei B, Jin W, Ruan J, Xu Z, Zhou Y, Liang J Tumour Biol. 2014; 36(2):1105-13.

PMID: 25326807 DOI: 10.1007/s13277-014-2695-1.